We use essential cookies to make this website work and to help improve it for you.
Change website language
Cymraeg – Newid yr iaith ir Gymraeg
English
Home
Every child in Wales deserves the best start in life. To be happy, healthy and have the care and attention they need to develop and grow. By creating the conditions […]
Category: Evidence and research
In 2018 Newborn Hearing Screening Wales (NBHSW) undertook a Quality Assurance (QA) review of audiology assessment and early support for children with significant hearing losses and their families, following referral […]
Category: Data and analysis, Evidence and research
The Screening Division of Public Health Wales is responsible for the planning, preparation and delivery of the Newborn Bloodspot Screening Wales (NBSW) programme. The programme offers every newborn baby who […]
This report is a detailed summary of information on work undertaken by Newborn Bloodspot Screening Wales for the financial year from April 2017 to the end of March 2018. Results […]
This report is a detailed summary of information on work undertaken by Newborn Bloodspot Screening Wales for the financial year from April 2018 to the end of March 2019. Results […]
This report is a detailed summary of information on work undertaken by Newborn Bloodspot Screening Wales for the financial year from April 2019 to the end of March 2020. Results […]
This report is a detailed summary of information on work undertaken by Newborn Bloodspot Screening Wales for the financial year from April 2020 to the end of March 2021. Results […]
This report is a detailed summary of information on work undertaken by Newborn Bloodspot Screening Wales for the financial year from April 2021 to the end of March 2022. Results […]
This WEDINOS report highlights a concerning trend in the UK’s illicit drug market: the infiltration of highly potent synthetic opioids, specifically nitazenes, into substances sold as benzodiazepines. The report underscores […]
Category: Annual reports, Drug testing (WEDINOS), Evidence and research, Monthly reports
This WEDINOS report highlights the increasing potency and variability of MDMA (ecstasy) tablets in the UK. The report emphasizes that the strength of MDMA tablets can vary widely, even within […]
